NCT00834119View on ClinicalTrials.gov

Assessment of Intranasal Steroids in Allergic Rhinitis When Used Alone or in Combination With an Oral Antihistamine (Study P03270)

PHASE4CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

September 1, 2003

Primary Completion Date

April 1, 2004

Study Completion Date

April 1, 2004

Conditions
Rhinitis, Allergic
Interventions
DRUG

Mometasone furoate

Mometasone furoate 200 mcg (2 puffs in each nostril) once a day for 28 days

DRUG

Mometasone furoate

Mometasone furoate 200 mcg (2 puffs in each nostril) once a day plus an oral antihistamine added at Day 28 (Visit 2) at the discretion of the physician

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00834119 - Assessment of Intranasal Steroids in Allergic Rhinitis When Used Alone or in Combination With an Oral Antihistamine (Study P03270) | Biotech Hunter | Biotech Hunter